STAT3 signaling in Tregs can upregulate the expression of TGF-β and IL-10, which conversely restrain IFN-γ production by CD8+ T cells, and finally inhibit the tumor-killing activity of CD8+ T cells [39]. Here, CD8A is linked to neoplasm.